Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

System-IGF-1 Pathway and Alzheimer's Disease (SIGAL)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00647478
First received: March 26, 2008
Last updated: June 5, 2013
Last verified: June 2013